Novartis

Is Allergan A Good Deal For Abbvie?

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AbbVie Inc. (ABBV): Free Stock Analysis Report Novartis AG (NVS): Free Stock Analysis...

Read More →

Conatus' Emricasan Lags Primary Goal In Liver Function Study

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Pfizer Inc. (PFE): Free Stock Analysis Report Novartis AG (NVS): Free Stock Analysis...
Related topics: Pfizer

Read More →

A Year After Approval, Migraine Drugs Are Changing Lives. But Insurance Battles Are Creating A...

Last May, the Food and Drug Administration (FDA) approved Amgen and Novartis’ Aimovig, the first drug specifically designed to prevent chronic migraines, and offered new hope to the millions of Americans regularly weathering these debilitating...
Related topics: Migraine, Food And Drug Administration, Amgen

Read More →

Fourth Carcinogen Found In "widely Prescribed" Blood Pressure Medicine

A fourth cancer-causing compound was found in widely prescribed blood pressure pills, according to a new report by Bloomberg. The solvent dimethylformamide was discovered in the drug valsartan, manufactured by several companies including Novartis,...
Related topics: Cancer, Blood Pressure, Oncology, Medical Research

Read More →

Nvs Or Nvo: Which Is The Better Value Stock Right Now?

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novartis AG (NVS): Free Stock Analysis Report Novo Nordisk A/S (NVO): Free Stock...

Read More →

Jazz's (jazz) New Sleep Drug Sunosi Gets Schedule Iv Status

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novartis AG (NVS): Free Stock Analysis Report Jazz Pharmaceuticals PLC (JAZZ): Free...

Read More →

Roche Reports Positive Data On Rituxan For Pemphigus Vulgaris

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novartis AG (NVS): Free Stock Analysis Report Roche Holding AG (RHHBY): Free Stock...

Read More →

Ligand Inks Oncology Drug Discovery Deal With Phoremost

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novartis AG (NVS): Free Stock Analysis Report Amgen Inc. (AMGN): Free Stock Analysis...
Related topics: Amgen

Read More →

Novartis Reports Data On Cosentyx For Psoriatic Arthritis

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report Pfizer Inc. (PFE):...
Related topics: Bristol-Myers Squibb, Pfizer

Read More →

Celgene's Filing For Ozanimod Accepted For Review In Us/eu

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novartis AG (NVS): Free Stock Analysis Report Celgene Corporation (CELG): Free Stock...

Read More →

Novartis Appoints New Pharma Unit Head, Gives Other Updates

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novartis AG (NVS): Free Stock Analysis Report Bristol-Myers Squibb Company (BMY):...
Related topics: Bristol-Myers Squibb

Read More →

Aduro Stock Crashes After Asco Updates On Cancer Candidate

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report Novartis AG (NVS): Free Stock...
Related topics: Merck & Co

Read More →

Monthly News Roundup - May 2019

Zolgensma: First Gene Therapy for Pediatric Spinal Muscular Atrophy (SMA) Zolgensma (onasemnogene abeparvovec-xioi) from AveXis (a Novartis company), is now approved for children less than 2 years of age with spinal muscular atrophy (SMA). SMA...
Related topics: Genetics

Read More →

Is The $2.1 Million Price Tag For Novartis' Zolgensma Ridiculous?

By tinkering with our genes, biopharma companies are making big breakthroughs that are revolutionizing how doctors treat disease. Last week, the Food and Drug Administration approved the latest of these game-changing therapies, Novartis'(NYSE:...
Related topics: Genetics, Food And Drug Administration

Read More →

Biogen Reports Interim Phase Iii Data On Diroximel Fumarate

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novartis AG (NVS): Free Stock Analysis Report Alkermes plc (ALKS): Free Stock...

Read More →

Novartis (nvs) Reports Positive Phase Iii Data On Asthma Drug

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Roche Holding AG (RHHBY): Free Stock Analysis Report Bristol-Myers Squibb Company...
Related topics: Bristol-Myers Squibb

Read More →

Pdl Biopharma's Royalties Help, Heavy Partner Reliance Hurts

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novartis AG (NVS): Free Stock Analysis Report PDL BioPharma, Inc. (PDLI): Free Stock...

Read More →

Incyte (incy) Receives Fda Nod For Label Expansion Of Jakafi

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report Novartis AG (NVS): Free Stock...
Related topics: Merck & Co

Read More →

Approval Of A Game-changing Gene Therapy For Sma Delivers A Win For Novartis And Regenxbio

There are over 6,000 genetic disorders, and most don't have any regulatory-approved treatment options. That's discouraging, but there's reason for hope; gene therapies are in development that aim to address the root cause of genetic diseases. On...
Related topics: Genetics

Read More →

Fda Oks Alpelisib, First Pi3k Inhibitor For Breast Cancer

The FDA approved alpelisib (Piqray, Novartis) to be used with the FDA-approved fulvestrant in certain patients with breast cancer. A companion test was also approved. FDA Approvals
Related topics: Food And Drug Administration, Breast Cancer, Cancer, Oncology

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.